PsychiatryOnline | American Journal of Psychiatry | Suspected Dronabinol Withdrawal in an Elderly Cannabis-Naive Medically Ill Patient

We attribute the onset and resolution of symptoms to the removal and addition of dronabinol because of their quick disappearance after reinitiation and their continued absence after discontinuing quetiapine. We recommend that potential withdrawal symptoms be considered during dronabinol use; tapering during discontinuation could prevent its occurrence. Additional studies are needed to better elucidate the details of phenomena such as the frequency of occurrence and dose-dependency in this population.

via PsychiatryOnline | American Journal of Psychiatry | Suspected Dronabinol Withdrawal in an Elderly Cannabis-Naive Medically Ill Patient.

A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy – Full Text View – ClinicalTrials.gov

This study has been completed.

via A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy – Full Text View – ClinicalTrials.gov.

A Double-Blind, Placebo-Controlled, Crossover Pilot Trial With Extension Using an Oral Mucosal Cannabinoid Extract for Treatment of Chemotherapy-Induced Neuropathic Pain

A Double-Blind, Placebo-Controlled, Crossover Pilot Trial With Extension Using an Oral Mucosal Cannabinoid Extract for Treatment of Chemotherapy-Induced Neuropathic Pain

via A Double-Blind, Placebo-Controlled, Crossover Pilot Trial With Extension Using an Oral Mucosal Cannabinoid Extract for Treatment of Chemotherapy-Induced Neuropathic Pain.